{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:01:25Z","timestamp":1773763285486,"version":"3.50.1"},"reference-count":25,"publisher":"SLACK, Inc.","issue":"S2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To determine the safety and efficacy of wavefront-guided LASIK for the correction of low to moderate myopia, as performed by surgeons employed by Optical Express, a large corporate provider.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data were extracted from the Optical Express central database on 22,900 patients (42,143 eyes) who underwent primary LASIK to treat low to moderate myopia and\/or astigmatism. All treatments used a wavefront-guided ablation profile and had a refractive target of emmetropia. Outcomes were evaluated using 1-month follow-up data, which were available for 32,569 eyes of 17,713 patients (77% follow-up). Complications were tabulated using all available data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mean manifest spherical equivalent (MSE) was reduced from \u22122.97\u00b11.33 diopters (D) (range: \u22120.37 to \u22126.00 D) to \u22120.03\u00b10.29 D (range: \u22123.50 to \u22124.50 D) 1 month after surgery. Ninety-four percent of eyes were within 0.50 D of the intended correction, and the correlation coefficient of the attempted versus achieved MSE was 0.96. Uncorrected visual acuity (UCVA) of 20\/20 or better was achieved in 92% of eyes; 99% of eyes achieved UCVA of 20\/40 or better. Among patients who had bilateral laser vision correction, 98% achieved 20\/20 uncorrected binocular vision. Average best spectacle-corrected visual acuity (BSCVA) improved slightly 1 month after surgery (mean change: +0.01 logMAR). There were 210 (0.67%) eyes that lost 2 or more lines of BSCVA; however, all eyes were 20\/40 or better. Intraoperative complications occurred in 25 eyes (0.06%; 1:1686), and postoperative complications occurred in 210 eyes (0.64%; 1:155). The most common complications were dry eye (n=58; 0.18%; 1:562) and mild diffuse lamellar keratitis (grade 1 or 2) (n=58; 0.18%; 1:562).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>\n              Wavefront-guided LASIK can safely and effectively correct low to moderate myopia, as demonstrated by 1-month postoperative visual outcomes from a large number of patients. [\n              <jats:italic>J Refract Surg<\/jats:italic>\n              . 2009;25: S634\u2013S641.]\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/1081597x-20090611-02","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T22:33:31Z","timestamp":1545604411000},"source":"Crossref","is-referenced-by-count":29,"title":["One-month Outcomes of Wavefront-guided LASIK for Low to Moderate Myopia With the VISX STAR S4 Laser in 32,569 Eyes"],"prefix":"10.3928","volume":"25","author":[{"given":"Steven C.","family":"Schallhorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20090611-06"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20090611-05"},{"key":"e_1_3_2_4_2","unstructured":"Professional use information. VISX STAR S4 IR\u2122 Excimer Laser System and WaveScan WaveFront\u00ae System. CustomVue\u2122 Treatment. Available at: www.accessdata.fda.gov\/cdrh_docs\/pdf\/P930016S020c.pdf. Accessed May 2009."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20090611-03"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2004.09.046"},{"key":"e_1_3_2_7_2","first-page":"S77","article-title":"Wavefront-guided excimer laser ablation using photorefractive keratectomy and sub-Bowman's keratomileusis: a contralateral eye study","volume":"24","author":"Durrie DS","year":"2008","unstructured":"Durrie DS, Slade SG, Marshall J. Wavefront-guided excimer laser ablation using photorefractive keratectomy and sub-Bowman's keratomileusis: a contralateral eye study. J Refract Surg. 2008;24:S77\u2013S84.","journal-title":"J Refract Surg"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20070601-10"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20050902-15"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20090301-06"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.038"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20070601-09"},{"key":"e_1_3_2_13_2","first-page":"S424","article-title":"Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: three-month results of a prospective FDA trial","volume":"24","author":"Stonecipher KG","year":"2008","unstructured":"Stonecipher KG, Kezirian GM. Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: three-month results of a prospective FDA trial. J Refract Surg. 2008;24:S424\u2013S430.","journal-title":"J Refract Surg"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040901-38"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040901-37"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040901-39"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20050902-17"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.11.036"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2006.02.043"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20041101-05"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702856"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20090611-08"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.07.019"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.11.1484"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.12.032"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.073"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T03:33:49Z","timestamp":1683084829000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20090611-02"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.3928\/1081597X-20090611-02"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20090611-02","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}